Literature DB >> 32388227

Timing of menarche and abnormal hippocampal connectivity in youth at clinical-high risk for psychosis.

Katherine S F Damme1, Ivanka Ristanovic2, Teresa Vargas2, Vijay A Mittal3.   

Abstract

The "estrogen hypothesis" suggests that estrogen is a protective factor against psychotic disorders such as schizophrenia. Although the precise protective mechanisms are still unclear, one potential explanation lies in the role that increased estrogens play in mediating hippocampal plasticity, as this may reduce hippocampal dysconnectivity that is characteristically observed in psychosis. In support of this view, later age at menarche- less available estrogen during critical early adolescent development- is related to earlier onset of psychosis and increased symptom severity. Furthermore, if estrogens have protective effects, then we should see this effect in the psychosis risk period in those at clinical high-risk (CHR) for psychosis - i.e., individuals showing attenuated symptoms at imminent risk for transitioning to a psychotic diagnosis. This study examined whether earlier age at menarche would result in more normative hippocampal connectivity in CHR youth; menarche is an easily assessed, developmental marker associated with the availability of estrogens. Resting-state connectivity was examined in sixty female participants (26 CHR and 34 healthy control; age 12-21) using a cross-sectional approach; hippocampal connectivity was found to relate to age at menarche. Later age at menarche in the CHR group related to increased hippocampal dysconnectivity to the occipital cortex (a region with a neurotrophic response to estrogen) compared to the controls. Results suggest that earlier availability of estrogens may have neuroprotective effects on hippocampal plasticity. Findings have relevance for understanding sex differences and etiology, as well as guiding novel treatments.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Connectivity; Development; Estrogen; Hippocampus; Prodrome; Psychosis

Mesh:

Substances:

Year:  2020        PMID: 32388227      PMCID: PMC7305941          DOI: 10.1016/j.psyneuen.2020.104672

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  51 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 2.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

3.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

4.  Testing a dual-systems model of adolescent brain development using resting-state connectivity analyses.

Authors:  A C K van Duijvenvoorde; M Achterberg; B R Braams; S Peters; E A Crone
Journal:  Neuroimage       Date:  2015-05-10       Impact factor: 6.556

5.  The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective.

Authors:  R Diaz Brinton; S Chen; M Montoya; D Hsieh; J Minaya; J Kim; H P Chu
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 6.  Oestrogen withdrawal associated psychoses.

Authors:  V Mahé; A Dumaine
Journal:  Acta Psychiatr Scand       Date:  2001-11       Impact factor: 6.392

7.  Modulation by estradiol of serotonin receptors in brain.

Authors:  A Biegon; B S McEwen
Journal:  J Neurosci       Date:  1982-02       Impact factor: 6.167

8.  Estradiol levels in psychotic disorders.

Authors:  T J Huber; J Rollnik; J Wilhelms; A von zur Mühlen; H M Emrich; U Schneider
Journal:  Psychoneuroendocrinology       Date:  2001-01       Impact factor: 4.905

9.  Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents.

Authors:  Vijay A Mittal; Elaine F Walker
Journal:  J Abnorm Psychol       Date:  2007-11

10.  Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis.

Authors:  Derek J Dean; Vijay A Mittal
Journal:  NPJ Schizophr       Date:  2015-03-04
View more
  4 in total

1.  Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation.

Authors:  Katherine S F Damme; Jason Schiffman; Lauren M Ellman; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

2.  Equity in Mental Health Services for Youth at Clinical High Risk for Psychosis: Considering Marginalized Identities and Stressors.

Authors:  Joseph S DeLuca; Derek M Novacek; Laura H Adery; Shaynna N Herrera; Yulia Landa; Cheryl M Corcoran; Elaine F Walker
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2022-03-23

Review 3.  The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders.

Authors:  Wu Jeong Hwang; Tae Young Lee; Nahrie Suk Kim; Jun Soo Kwon
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

4.  Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function.

Authors:  Paul Allen; Emily J Hird; Natasza Orlov; Gemma Modinos; Matthijs Bossong; Mathilde Antoniades; Carly Sampson; Matilda Azis; Oliver Howes; James Stone; Jesus Perez; Matthew Broome; Anthony A Grace; Philip McGuire
Journal:  Transl Psychiatry       Date:  2021-11-10       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.